ValuEngine upgraded shares of Nu Skin Enterprises, Inc. (NYSE:NUS) from a hold rating to a buy rating in a research report sent to investors on Tuesday.

A number of other research analysts have also commented on the company. Zacks Investment Research lowered Nu Skin Enterprises from a hold rating to a sell rating in a research report on Tuesday, October 17th. TheStreet raised Nu Skin Enterprises from a c+ rating to a b rating in a research report on Wednesday, August 2nd. Stifel Nicolaus set a $50.00 price target on Nu Skin Enterprises and gave the company a sell rating in a research report on Thursday, August 3rd. Finally, BidaskClub lowered Nu Skin Enterprises from a strong-buy rating to a buy rating in a research report on Monday, July 31st. Three equities research analysts have rated the stock with a sell rating, two have given a hold rating and four have assigned a buy rating to the company’s stock. The company presently has an average rating of Hold and a consensus price target of $62.00.

Shares of Nu Skin Enterprises (NYSE NUS) opened at $63.65 on Tuesday. Nu Skin Enterprises has a 52 week low of $46.35 and a 52 week high of $65.85. The company has a quick ratio of 1.18, a current ratio of 1.78 and a debt-to-equity ratio of 0.44. The firm has a market capitalization of $3,350.00, a PE ratio of 22.28, a PEG ratio of 2.29 and a beta of 1.56.

Nu Skin Enterprises (NYSE:NUS) last released its earnings results on Wednesday, November 1st. The company reported $0.76 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.76. The company had revenue of $563.70 million during the quarter, compared to analyst estimates of $562.70 million. Nu Skin Enterprises had a return on equity of 22.38% and a net margin of 6.97%. Nu Skin Enterprises’s revenue for the quarter was down 6.7% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.98 EPS. analysts expect that Nu Skin Enterprises will post 3.23 earnings per share for the current year.

ILLEGAL ACTIVITY WARNING: “Nu Skin Enterprises, Inc. (NUS) Stock Rating Upgraded by ValuEngine” was originally posted by Daily Political and is the property of of Daily Political. If you are reading this article on another publication, it was illegally copied and republished in violation of United States & international trademark and copyright law. The legal version of this article can be read at https://www.dailypolitical.com/2017/11/18/nu-skin-enterprises-inc-nus-stock-rating-upgraded-by-valuengine.html.

The company also recently announced a quarterly dividend, which will be paid on Wednesday, December 6th. Stockholders of record on Friday, November 17th will be given a $0.36 dividend. This represents a $1.44 annualized dividend and a dividend yield of 2.26%. The ex-dividend date of this dividend is Thursday, November 16th. Nu Skin Enterprises’s dividend payout ratio is currently 52.75%.

In other news, Director Daniel W. Campbell sold 4,607 shares of the stock in a transaction that occurred on Thursday, September 7th. The stock was sold at an average price of $62.48, for a total value of $287,845.36. Following the completion of the transaction, the director now owns 63,753 shares of the company’s stock, valued at approximately $3,983,287.44. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Joseph Y. Chang sold 13,497 shares of the stock in a transaction that occurred on Wednesday, November 8th. The stock was sold at an average price of $62.06, for a total value of $837,623.82. Following the completion of the transaction, the insider now directly owns 66,563 shares of the company’s stock, valued at approximately $4,130,899.78. The disclosure for this sale can be found here. Insiders sold a total of 73,207 shares of company stock valued at $4,585,949 in the last three months. Corporate insiders own 5.20% of the company’s stock.

Several large investors have recently made changes to their positions in the company. California Public Employees Retirement System raised its position in shares of Nu Skin Enterprises by 5.0% in the 3rd quarter. California Public Employees Retirement System now owns 143,813 shares of the company’s stock worth $8,842,000 after acquiring an additional 6,913 shares in the last quarter. Janus Henderson Group PLC raised its position in shares of Nu Skin Enterprises by 251.6% in the 3rd quarter. Janus Henderson Group PLC now owns 110,400 shares of the company’s stock worth $6,787,000 after acquiring an additional 79,000 shares in the last quarter. Cornerstone Capital Management Holdings LLC. raised its position in shares of Nu Skin Enterprises by 14.1% in the 3rd quarter. Cornerstone Capital Management Holdings LLC. now owns 321,219 shares of the company’s stock worth $19,747,000 after acquiring an additional 39,665 shares in the last quarter. Allianz Asset Management GmbH bought a new position in shares of Nu Skin Enterprises in the 3rd quarter worth approximately $4,648,000. Finally, Convergence Investment Partners LLC raised its position in shares of Nu Skin Enterprises by 14.2% in the 3rd quarter. Convergence Investment Partners LLC now owns 65,602 shares of the company’s stock worth $4,033,000 after acquiring an additional 8,134 shares in the last quarter. 80.13% of the stock is owned by hedge funds and other institutional investors.

Nu Skin Enterprises Company Profile

Nu Skin Enterprises, Inc is a direct selling company that develops and distributes personal care products and nutritional supplements, and a range of other products and services. The Company offers anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands. The Nu Skin brand offers a range of products, including ageLOC Me customized skin care system, ageLOC Spa systems and ageLOC Transformation anti-aging skin care system.

To view ValuEngine’s full report, visit ValuEngine’s official website.

Analyst Recommendations for Nu Skin Enterprises (NYSE:NUS)

Receive News & Ratings for Nu Skin Enterprises Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises Inc. and related companies with MarketBeat.com's FREE daily email newsletter.